Why Oncologists Are Prescribing GLP-1s
Why Oncologists Are Prescribing GLP-1s

Why Oncologists Are Prescribing GLP-1s

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

Given the increasing prevalence of weight-related conditions and the rapid uptake of GLP-1s on the one hand, and the increasing incidence of cancer on the other hand, it was inevitable that these two worlds would collide. In this paper, we uncover what's really happening at the intersection of two of healthcare's most defining challenges.

Improved patient outcomes, reduced treatment toxicity, enhanced drug efficacy – oncologists are finding compelling reasons to reach for GLP-1s. But concerns around drug interactions and unclear long-term effects reveal a more complex picture.

This essential read provides evidence-based understanding of why cancer specialists are embracing – and sometimes avoiding – this rapidly expanding drug class, and what clarity the industry needs to provide.

Why Oncologists Are Prescribing GLP-1s

Why Oncologists Are Prescribing GLP-1s

Explore the Findings

The author(s)

  • Pieter De Richter
    Pieter De Richter
    Regional Service Line Leader, Healthcare in APAC, Malaysia

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights
    Artificial Intelligence (AI) Events replay

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.